Connect your AI

BioLife Solutions BLFS Total Liabilities

Total Liabilities at other companies

AzentaAZTA

$32.12M—

LeMaitre VascularLMAT

$222.9M+6.9%

CryoPort, Inc.CYRX

$268.62M-10.8%

RevvityRVTY

$4.81B+1.9%

Baxter InternationalBAX

$62M-99.6%

Thermo Fisher ScientificTMO

——

Other financials

Income statement

Revenue$27.5M+24.7%

Gross profit$17.5M+18.2%

Operating income$27.0K+105%

Net income$1.2M+365%

EPS (diluted)$0.02—

Balance sheet

Cash & equivalents$22.8M-65.9%

Total debt$17.4M-35.6%

Total equity$372.2M+5.6%

Total assets$400.9M+1.5%

Cash flow

Operating cash flow-$491.0K-128%

CapEx$167.0K-4.6%

Free cash flow-$658.0K-142%

Valuation

Market cap$1.25B+33.1%

Enterprise value$1.24B+38.1%

P/S12.5×+0.5×

Profitability

Gross margin66.9%—

Operating margin-16.7%—

Net margin-68.7%—

FCF margin-15.9%+18.7pp

Returns & leverage

Return on equity-14.5%-4.7pp

Debt / equity0×0.0×

Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is BioLife Solutions's total liabilities?: BioLife Solutions (BLFS) reported total liabilities of $28.68M in Q1 2026.
How has BioLife Solutions's total liabilities changed year-over-year?: BioLife Solutions's total liabilities decreased by 32.6% year-over-year, from $42.52M to $28.68M.
What is the long-term trend for BioLife Solutions's total liabilities?: Over 5 years (2020 to 2025), BioLife Solutions's total liabilities has grown at a 2.8% compound annual growth rate (CAGR), from $29.58M to $34M.
What does total liabilities mean?: The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.